Study period:~Index date: The index date were defined as the first date of the first prescription of Sacubitril/Valsartan during inclusion period and this were used to establish the beginning of the follow-up period.~Characterization period: 6 months period before the index date were used to characterize patients.~Follow-up period: Any patients has at least 1 year of follow-up. Follow-up period went from index date to June 2020.
The study is a cohort observational, retrospective, non-interventional study.